Jupiter Wellness reopens January – GuruFocus.com

Jupiter Wellness reopens January – GuruFocus.com

Clinical trial patient enrollment expected to complete in December 2022

JUPITER, FL / ACCESSWIRE / Nov 10, 2022 / Jupiter WellnessInc. (Nasdaq:JUPW)a wellness company focused on hair loss, eczema, burns and sexual wellness, announced today that it has reopened enrollment in a clinical trial aimed at evaluating the superiority of JW-100, a new topical cannabidiol cream , in a head treatment. comparative study against EUCRISA, an FDA-approved topical treatment for eczema developed by Pfizer.

The study was discontinued to resolve stability issues in the original formulation of JW-100. These issues were addressed and resolved to the satisfaction of the study’s clinical investigators.

Jupiter Wellness CEO Brian John said: “Due to the nature of a double-blind study, we can only access certain data from the first run of this trial. However, what we have seen suggests to our team of scientists that they are on the right track and that this study warrants continuation. We are very encouraged by this update and look forward to showing that our JW-100 is as effective, if not superior, to a leading drug already on the market generating hundreds of million in revenue. We look forward to having the second half of this journey completed in the first quarter of 2023.”

About Jupiter Wellness
Jupiter Wellness is a diversified company that supports health and wellness through the research and development of over-the-counter (OTC) products and intellectual property. The Company’s product portfolio addresses a variety of conditions, including hair loss, eczema, burns and sexual wellness. Revenue is generated through sales of OTC and consumer products, contract research agreements, and license royalties.

Investors and interested shareholders are encouraged to sign up for press releases and industry updates by signing up for email alerts at https://jupiterwellness.com/email-alerts/ and following Jupiter Wellness on Twitter Y LinkedIn.

Media contact

Phone: 561-244-7100
Email: [email protected]

Contact for investors

Phone: 561-244-7100
Email: [email protected]

Forward-looking statements

This release contains forward-looking statements regarding Jupiter Wellness, including the anticipated timing of the studies and the results and benefits of the studies. In general, you can identify forward-looking statements by using forward-looking terminology such as “anticipate”, “believe”, “continue”, “may”, “estimate”, “expect”, “explore”, “assess”, “intend” , “may”, “could”, “plan”, “potential”, “predict”, “project”, “seek”, “should” or “will”, or the negative thereof or other variations thereof or comparable terminology. These forward-looking statements are based on each of the Company’s current plans, objectives, estimates, expectations and intentions and inherently involve significant risks and uncertainties, many of which are beyond the control of Jupiter Wellness. Actual results and timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties and other risks and uncertainties affecting Jupiter Wellness, including those described from time to time under the heading “Risk Factors.” and elsewhere in Jupiter Wellness Securities and Exchange Commission (SEC) filings and reports, including Jupiter Wellness Annual Report on Form 10-K for the year ended December 31, 2021, and future presentations and reports from Jupiter Wellness. In addition, other risks and uncertainties of which the combined company is not currently aware may also affect each of the companies’ forward-looking statements and may cause actual results and timing of events to differ materially from those anticipated. Investors are cautioned that forward-looking statements are not guarantees of future performance. The forward-looking statements made in this release are made only as of the date hereof or the dates indicated in the forward-looking statements and reflect the views expressed therein regarding future events on such dates, even if made later. available by Jupiter Wellness on its website or otherwise. Jupiter Wellness undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date any forward-looking statements are made.

FONT: Jupiter Wellness Inc.

See the source version at accesswire.com:
https://www.accesswire.com/724757/Jupiter-Wellness-Re-Opens-Enrollment-in-Clinical-Trial-Comparison-of-JW-100-and-EUCRISA-for-the-Treatment-of-Eczema

img.ashx?id=724757

Leave a Comment